Through the latest generation of its Continental European fund, Bain Capital entered into exclusive negotiations to acquire control of the healthcare software publisher.

The final share allocation at closing will depend on the level of reinvestment by the selling shareholders, including Five Arrows  which held 60 % of the business since 2020  and Naxicap Partners, which has been invested since 2009.

In 2024, Softway Medical reported revenues of €150 million and is targeting €175 million for the current year, supported by strong organic growth of between 15% and 20%. Headquartered in Fuveau, near Aix-en-Provence, the Group deploys its cloud-native solutions to more than 1,300 hospitals and clinics representing approximately 40% market share as well as 1,300 radiology centres, 700 care centres and 400 laboratories.

Softway Medical already employs over 1,200 people and plans to hire between 150 and 200 employees per year through 2030 to support its growth under the eNov development plan. The company also pursues an ambitious external growth strategy, with ten acquisitions completed to date, including three in 2024: SBIM (Belgium), EpiConcept (epidemiology and health data), and a distribution agreement in Canada. Altogether, these transactions account for several tens of millions of euros in investment